カテゴリー： LP Information, 世界, 医療/バイオ

世界の降圧薬市場予測 2021年-2026年

【英語タイトル】Global Anti-Hypertensive Drugs Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9420）・商品コード：LPI21MY9420
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：132
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「降圧薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシン受容体遮断薬（ARB）、カルシウムチャネル遮断薬、ベータ遮断薬、アルファ遮断薬、血管拡張薬、レニン阻害薬など、用途別には、病院薬局、小売薬局、オンライン薬局などにセグメント区分してまとめました。降圧薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・降圧薬の世界市場概要（サマリー）
・降圧薬の企業別販売量・売上
・降圧薬の企業別市場シェア
・降圧薬の世界市場規模 2016年-2021年：種類別（利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシン受容体遮断薬（ARB）、カルシウムチャネル遮断薬、ベータ遮断薬、アルファ遮断薬、血管拡張薬、レニン阻害薬）
・降圧薬の世界市場規模 2016年-2021年：用途別（病院薬局、小売薬局、オンライン薬局）
・降圧薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・降圧薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・降圧薬のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・降圧薬の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・降圧薬市場の成長要因・課題・動向
・降圧薬の世界市場予測 2021年-2026年
・降圧薬の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・降圧薬のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・降圧薬のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・降圧薬の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・降圧薬の世界市場予測：種類別（利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシン受容体遮断薬（ARB）、カルシウムチャネル遮断薬、ベータ遮断薬、アルファ遮断薬、血管拡張薬、レニン阻害薬）
・降圧薬の世界市場予測：用途別（病院薬局、小売薬局、オンライン薬局）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Anti-Hypertensive Drugs will have significant change from previous year. By the most conservative estimates of global Anti-Hypertensive Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 39390 million in 2019. Over the next five years the Anti-Hypertensive Drugs market will register a 1.7% CAGR in terms of revenue, the global market size will reach US$ 42110 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Hypertensive Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Calcium Channel Blockers
Beta Blockers
Alpha Blockers
Vasodilators
Renin Inhibitors

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Novartis
Pfizer
Johnson & Johnson
Sanofi
Lupin
Ranbaxy Laboratories
Merck
AstraZeneca
Daiichi Sankyo Company Limited
Takeda Pharmaceutical

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-Hypertensive Drugs Consumption 2016-2026
2.1.2 Anti-Hypertensive Drugs Consumption CAGR by Region
2.2 Anti-Hypertensive Drugs Segment by Type
2.2.1 Diuretics
2.2.2 Angiotensin Converting Enzyme (ACE) Inhibitors
2.2.3 Angiotensin Receptor Blockers (ARBs)
2.2.4 Calcium Channel Blockers
2.2.5 Beta Blockers
2.2.6 Alpha Blockers
2.2.7 Vasodilators
2.2.8 Renin Inhibitors
2.3 Anti-Hypertensive Drugs Sales by Type
2.3.1 Global Anti-Hypertensive Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Anti-Hypertensive Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Anti-Hypertensive Drugs Sale Price by Type (2016-2021)
2.4 Anti-Hypertensive Drugs Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Anti-Hypertensive Drugs Sales by Application
2.5.1 Global Anti-Hypertensive Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Anti-Hypertensive Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Anti-Hypertensive Drugs Sale Price by Application (2016-2021)

3 Global Anti-Hypertensive Drugs by Company
3.1 Global Anti-Hypertensive Drugs Sales Market Share by Company
3.1.1 Global Anti-Hypertensive Drugs Sales by Company (2019-2021)
3.1.2 Global Anti-Hypertensive Drugs Sales Market Share by Company (2019-2021)
3.2 Global Anti-Hypertensive Drugs Revenue Market Share by Company
3.2.1 Global Anti-Hypertensive Drugs Revenue by Company (2019-2021)
3.2.2 Global Anti-Hypertensive Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Anti-Hypertensive Drugs Sale Price by Company
3.4 Global Manufacturers Anti-Hypertensive Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Hypertensive Drugs Product Location Distribution
3.4.2 Players Anti-Hypertensive Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Anti-Hypertensive Drugs by Region
4.1 Global Anti-Hypertensive Drugs by Region
4.1.1 Global Anti-Hypertensive Drugs Sales by Region
4.1.2 Global Anti-Hypertensive Drugs Revenue by Region
4.2 Americas Anti-Hypertensive Drugs Sales Growth
4.3 APAC Anti-Hypertensive Drugs Sales Growth
4.4 Europe Anti-Hypertensive Drugs Sales Growth
4.5 Middle East & Africa Anti-Hypertensive Drugs Sales Growth

5 Americas
5.1 Americas Anti-Hypertensive Drugs Sales by Country
5.1.1 Americas Anti-Hypertensive Drugs Sales by Country (2016-2021)
5.1.2 Americas Anti-Hypertensive Drugs Revenue by Country (2016-2021)
5.2 Americas Anti-Hypertensive Drugs Sales by Type
5.3 Americas Anti-Hypertensive Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Anti-Hypertensive Drugs Sales by Region
6.1.1 APAC Anti-Hypertensive Drugs Sales by Region (2016-2021)
6.1.2 APAC Anti-Hypertensive Drugs Revenue by Region (2016-2021)
6.2 APAC Anti-Hypertensive Drugs Sales by Type
6.3 APAC Anti-Hypertensive Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Anti-Hypertensive Drugs by Country
7.1.1 Europe Anti-Hypertensive Drugs Sales by Country (2016-2021)
7.1.2 Europe Anti-Hypertensive Drugs Revenue by Country (2016-2021)
7.2 Europe Anti-Hypertensive Drugs Sales by Type
7.3 Europe Anti-Hypertensive Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Anti-Hypertensive Drugs by Country
8.1.1 Middle East & Africa Anti-Hypertensive Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Anti-Hypertensive Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Anti-Hypertensive Drugs Sales by Type
8.3 Middle East & Africa Anti-Hypertensive Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Anti-Hypertensive Drugs Distributors
10.3 Anti-Hypertensive Drugs Customer

11 Global Anti-Hypertensive Drugs Market Forecast
11.1 Global Anti-Hypertensive Drugs Forecast by Region
11.1.1 Global Anti-Hypertensive Drugs Forecast by Regions (2021-2026)
11.2.2 Global Anti-Hypertensive Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Anti-Hypertensive Drugs Forecast by Type
11.7 Global Anti-Hypertensive Drugs Forecast by Application

12 Key Players Analysis
12.1 Novartis
12.1.1 Novartis Novartis Company Information
12.1.2 Novartis Anti-Hypertensive Drugs Product Offered
12.1.3 Novartis Anti-Hypertensive Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Novartis Main Business Overview
12.1.5 Novartis Latest Developments
12.2 Pfizer
12.2.1 Pfizer Company Information
12.2.2 Pfizer Anti-Hypertensive Drugs Product Offered
12.2.3 Pfizer Anti-Hypertensive Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Pfizer Main Business Overview
12.2.5 Pfizer Latest Developments
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Information
12.3.2 Johnson & Johnson Anti-Hypertensive Drugs Product Offered
12.3.3 Johnson & Johnson Anti-Hypertensive Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Johnson & Johnson Main Business Overview
12.3.5 Johnson & Johnson Latest Developments
12.4 Sanofi
12.4.1 Sanofi Company Information
12.4.2 Sanofi Anti-Hypertensive Drugs Product Offered
12.4.3 Sanofi Anti-Hypertensive Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Sanofi Main Business Overview
12.4.5 Sanofi Latest Developments
12.5 Lupin
12.5.1 Lupin Company Information
12.5.2 Lupin Anti-Hypertensive Drugs Product Offered
12.5.3 Lupin Anti-Hypertensive Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Lupin Main Business Overview
12.5.5 Lupin Latest Developments
12.6 Ranbaxy Laboratories
12.6.1 Ranbaxy Laboratories Company Information
12.6.2 Ranbaxy Laboratories Anti-Hypertensive Drugs Product Offered
12.6.3 Ranbaxy Laboratories Anti-Hypertensive Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Ranbaxy Laboratories Main Business Overview
12.6.5 Ranbaxy Laboratories Latest Developments
12.7 Merck
12.7.1 Merck Company Information
12.7.2 Merck Anti-Hypertensive Drugs Product Offered
12.7.3 Merck Anti-Hypertensive Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Merck Main Business Overview
12.7.5 Merck Latest Developments
12.8 AstraZeneca
12.8.1 AstraZeneca Company Information
12.8.2 AstraZeneca Anti-Hypertensive Drugs Product Offered
12.8.3 AstraZeneca Anti-Hypertensive Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 AstraZeneca Main Business Overview
12.8.5 AstraZeneca Latest Developments
12.9 Daiichi Sankyo Company Limited
12.9.1 Daiichi Sankyo Company Limited Company Information
12.9.2 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Product Offered
12.9.3 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Daiichi Sankyo Company Limited Main Business Overview
12.9.5 Daiichi Sankyo Company Limited Latest Developments
12.10 Takeda Pharmaceutical
12.10.1 Takeda Pharmaceutical Company Information
12.10.2 Takeda Pharmaceutical Anti-Hypertensive Drugs Product Offered
12.10.3 Takeda Pharmaceutical Anti-Hypertensive Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Takeda Pharmaceutical Main Business Overview
12.10.5 Takeda Pharmaceutical Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Anti-Hypertensive Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Diuretics
Table 3. Major Players of Angiotensin Converting Enzyme (ACE) Inhibitors
Table 4. Major Players of Angiotensin Receptor Blockers (ARBs)
Table 5. Major Players of Calcium Channel Blockers
Table 6. Major Players of Beta Blockers
Table 7. Major Players of Alpha Blockers
Table 8. Major Players of Vasodilators
Table 9. Major Players of Renin Inhibitors
Table 10. Global Anti-Hypertensive Drugs Sales by Type (2016-2021) & (K Units)
Table 11. Global Anti-Hypertensive Drugs Sales Market Share by Type (2016-2021)
Table 12. Global Anti-Hypertensive Drugs Revenue by Type (2016-2021) & ($ million)
Table 13. Global Anti-Hypertensive Drugs Revenue Market Share by Type (2016-2021)
Table 14. Global Anti-Hypertensive Drugs Sale Price by Type (2016-2021)
Table 15. Global Anti-Hypertensive Drugs Sales by Application (2016-2021) & (K Units)
Table 16. Global Anti-Hypertensive Drugs Sales Market Share by Application (2016-2021)
Table 17. Global Anti-Hypertensive Drugs Value by Application (2016-2021)
Table 18. Global Anti-Hypertensive Drugs Revenue Market Share by Application (2016-2021)
Table 19. Global Anti-Hypertensive Drugs Sale Price by Application (2016-2021)
Table 20. Global Anti-Hypertensive Drugs Sales by Company (2019-2021) & (K Units)
Table 21. Global Anti-Hypertensive Drugs Sales Market Share by Company (2019-2021)
Table 22. Global Anti-Hypertensive Drugs Revenue by Company (2019-2021) ($ Millions)
Table 23. Global Anti-Hypertensive Drugs Revenue Market Share by Company (2019-2021)
Table 24. Global Anti-Hypertensive Drugs Sale Price by Company (2019-2021)
Table 25. Key Manufacturers Anti-Hypertensive Drugs Producing Area Distribution and Sales Area
Table 26. Players Anti-Hypertensive Drugs Products Offered
Table 27. Anti-Hypertensive Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Anti-Hypertensive Drugs Sales by Region (2016-2021) (K Units)
Table 31. Global Anti-Hypertensive Drugs Sales Market Share by Region (2016-2021)
Table 32. Global Anti-Hypertensive Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 33. Global Anti-Hypertensive Drugs Revenue Market Share by Region (2016-2021)
Table 34. Americas Anti-Hypertensive Drugs Sales by Country (2016-2021) & (K Units)
Table 35. Americas Anti-Hypertensive Drugs Sales Market Share by Country (2016-2021)
Table 36. Americas Anti-Hypertensive Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 37. Americas Anti-Hypertensive Drugs Revenue Market Share by Country (2016-2021)
Table 38. Americas Anti-Hypertensive Drugs Sales by Type (2016-2021) & (K Units)
Table 39. Americas Anti-Hypertensive Drugs Sales Market Share by Type (2016-2021)
Table 40. Americas Anti-Hypertensive Drugs Sales by Application (2016-2021) & (K Units)
Table 41. Americas Anti-Hypertensive Drugs Sales Market Share by Application (2016-2021)
Table 42. APAC Anti-Hypertensive Drugs Sales by Region (2016-2021) & (K Units)
Table 43. APAC Anti-Hypertensive Drugs Sales Market Share by Region (2016-2021)
Table 44. APAC Anti-Hypertensive Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 45. APAC Anti-Hypertensive Drugs Revenue Market Share by Region (2016-2021)
Table 46. APAC Anti-Hypertensive Drugs Sales by Type (2016-2021) & (K Units)
Table 47. APAC Anti-Hypertensive Drugs Sales Market Share by Type (2016-2021)
Table 48. APAC Anti-Hypertensive Drugs Sales by Application (2016-2021) & (K Units)
Table 49. APAC Anti-Hypertensive Drugs Sales Market Share by Application (2016-2021)
Table 50. Europe Anti-Hypertensive Drugs Sales by Country (2016-2021) & (K Units)
Table 51. Europe Anti-Hypertensive Drugs Sales Market Share by Country (2016-2021)
Table 52. Europe Anti-Hypertensive Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 53. Europe Anti-Hypertensive Drugs Revenue Market Share by Country (2016-2021)
Table 54. Europe Anti-Hypertensive Drugs Sales by Type (2016-2021) & (K Units)
Table 55. Europe Anti-Hypertensive Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Anti-Hypertensive Drugs Sales by Application (2016-2021) & (K Units)
Table 57. Europe Anti-Hypertensive Drugs Sales Market Share by Application (2016-2021)
Table 58. Middle East & Africa Anti-Hypertensive Drugs Sales by Country (2016-2021) & (K Units)
Table 59. Middle East & Africa Anti-Hypertensive Drugs Sales Market Share by Country (2016-2021)
Table 60. Middle East & Africa Anti-Hypertensive Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 61. Middle East & Africa Anti-Hypertensive Drugs Revenue Market Share by Country (2016-2021)
Table 62. Middle East & Africa Anti-Hypertensive Drugs Sales by Type (2016-2021) & (K Units)
Table 63. Middle East & Africa Anti-Hypertensive Drugs Sales Market Share by Type (2016-2021)
Table 64. Middle East & Africa Anti-Hypertensive Drugs Sales by Application (2016-2021) & (K Units)
Table 65. Middle East & Africa Anti-Hypertensive Drugs Sales Market Share by Application (2016-2021)
Table 66. Global Anti-Hypertensive Drugs Sales Forecast by Type (2021-2026) & (K Units)
Table 67. Global Anti-Hypertensive Drugs Sales Market Share Forecast by Type (2021-2026)
Table 68. Global Anti-Hypertensive Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 69. Global Anti-Hypertensive Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 70. Global Anti-Hypertensive Drugs Sales Forecast by Application (2021-2026) & (K Units)
Table 71. Global Anti-Hypertensive Drugs Sales Market Share Forecast by Application (2021-2026)
Table 72. Global Anti-Hypertensive Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 73. Global Anti-Hypertensive Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 74. Novartis Basic Information, Anti-Hypertensive Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Novartis Anti-Hypertensive Drugs Product Offered
Table 76. Novartis Anti-Hypertensive Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 77. Novartis Main Business
Table 78. Novartis Latest Developments
Table 79. Pfizer Basic Information, Anti-Hypertensive Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Anti-Hypertensive Drugs Product Offered
Table 81. Pfizer Anti-Hypertensive Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 82. Pfizer Main Business
Table 83. Pfizer Latest Developments
Table 84. Johnson & Johnson Basic Information, Anti-Hypertensive Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Johnson & Johnson Anti-Hypertensive Drugs Product Offered
Table 86. Johnson & Johnson Anti-Hypertensive Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 87. Johnson & Johnson Main Business
Table 88. Johnson & Johnson Latest Developments
Table 89. Sanofi Basic Information, Anti-Hypertensive Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Sanofi Anti-Hypertensive Drugs Product Offered
Table 91. Sanofi Anti-Hypertensive Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 92. Sanofi Main Business
Table 93. Sanofi Latest Developments
Table 94. Lupin Basic Information, Anti-Hypertensive Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Lupin Anti-Hypertensive Drugs Product Offered
Table 96. Lupin Anti-Hypertensive Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 97. Lupin Main Business
Table 98. Lupin Latest Developments
Table 99. Ranbaxy Laboratories Basic Information, Anti-Hypertensive Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Ranbaxy Laboratories Anti-Hypertensive Drugs Product Offered
Table 101. Ranbaxy Laboratories Anti-Hypertensive Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 102. Ranbaxy Laboratories Main Business
Table 103. Ranbaxy Laboratories Latest Developments
Table 104. Merck Basic Information, Anti-Hypertensive Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Merck Anti-Hypertensive Drugs Product Offered
Table 106. Merck Anti-Hypertensive Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 107. Merck Main Business
Table 108. Merck Latest Developments
Table 109. AstraZeneca Basic Information, Anti-Hypertensive Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. AstraZeneca Anti-Hypertensive Drugs Product Offered
Table 111. AstraZeneca Anti-Hypertensive Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 112. AstraZeneca Main Business
Table 113. AstraZeneca Latest Developments
Table 114. Daiichi Sankyo Company Limited Basic Information, Anti-Hypertensive Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Product Offered
Table 116. Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 117. Daiichi Sankyo Company Limited Main Business
Table 118. Daiichi Sankyo Company Limited Latest Developments
Table 119. Takeda Pharmaceutical Basic Information, Anti-Hypertensive Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Takeda Pharmaceutical Anti-Hypertensive Drugs Product Offered
Table 121. Takeda Pharmaceutical Anti-Hypertensive Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 122. Takeda Pharmaceutical Main Business
Table 123. Takeda Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Anti-Hypertensive Drugs
Figure 2. Anti-Hypertensive Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Hypertensive Drugs Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Anti-Hypertensive Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Anti-Hypertensive Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Diuretics
Figure 10. Product Picture of Angiotensin Converting Enzyme (ACE) Inhibitors
Figure 11. Product Picture of Angiotensin Receptor Blockers (ARBs)
Figure 12. Product Picture of Calcium Channel Blockers
Figure 13. Product Picture of Beta Blockers
Figure 14. Product Picture of Alpha Blockers
Figure 15. Product Picture of Vasodilators
Figure 16. Product Picture of Renin Inhibitors
Figure 17. Global Anti-Hypertensive Drugs Sales Market Share by Type in 2020
Figure 18. Global Anti-Hypertensive Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Anti-Hypertensive Drugs Consumed in Hospital Pharmacies
Figure 20. Global Anti-Hypertensive Drugs Market: Hospital Pharmacies (2016-2021) & (K Units)
Figure 21. Anti-Hypertensive Drugs Consumed in Retail Pharmacies
Figure 22. Global Anti-Hypertensive Drugs Market: Retail Pharmacies (2016-2021) & (K Units)
Figure 23. Anti-Hypertensive Drugs Consumed in Online Pharmacies
Figure 24. Global Anti-Hypertensive Drugs Market: Online Pharmacies (2016-2021) & (K Units)
Figure 25. Global Anti-Hypertensive Drugs Sales Market Share by Application (2016-2021)
Figure 26. Global Anti-Hypertensive Drugs Revenue Market Share by Application in 2020
Figure 27. Global Anti-Hypertensive Drugs Revenue Market by Company in 2020 ($ Million)
Figure 28. Global Anti-Hypertensive Drugs Revenue Market Share by Company in 2020
Figure 29. Global Anti-Hypertensive Drugs Sales Market Share by Regions (2016-2021)
Figure 30. Global Anti-Hypertensive Drugs Revenue Market Share by Region in 2020
Figure 31. Americas Anti-Hypertensive Drugs Sales 2016-2021 (K Units)
Figure 32. Americas Anti-Hypertensive Drugs Revenue 2016-2021 ($ Millions)
Figure 33. APAC Anti-Hypertensive Drugs Sales 2016-2021 (K Units)
Figure 34. APAC Anti-Hypertensive Drugs Revenue 2016-2021 ($ Millions)
Figure 35. Europe Anti-Hypertensive Drugs Sales 2016-2021 (K Units)
Figure 36. Europe Anti-Hypertensive Drugs Revenue 2016-2021 ($ Millions)
Figure 37. Middle East & Africa Anti-Hypertensive Drugs Sales 2016-2021 (K Units)
Figure 38. Middle East & Africa Anti-Hypertensive Drugs Revenue 2016-2021 ($ Millions)
Figure 39. Americas Anti-Hypertensive Drugs Sales Market Share by Country in 2020
Figure 40. Americas Anti-Hypertensive Drugs Revenue Market Share by Country in 2020
Figure 41. Americas Anti-Hypertensive Drugs Sales Market Share by Type in 2020
Figure 42. Americas Anti-Hypertensive Drugs Sales Market Share by Application in 2020
Figure 43. United States Anti-Hypertensive Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 44. Canada Anti-Hypertensive Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 45. Mexico Anti-Hypertensive Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 46. Brazil Anti-Hypertensive Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 47. APAC Anti-Hypertensive Drugs Sales Market Share by Region in 2020
Figure 48. APAC Anti-Hypertensive Drugs Revenue Market Share by Regions in 2020
Figure 49. APAC Anti-Hypertensive Drugs Sales Market Share by Type in 2020
Figure 50. APAC Anti-Hypertensive Drugs Sales Market Share by Application in 2020
Figure 51. China Anti-Hypertensive Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 52. Japan Anti-Hypertensive Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 53. Korea Anti-Hypertensive Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 54. Southeast Asia Anti-Hypertensive Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 55. India Anti-Hypertensive Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 56. Australia Anti-Hypertensive Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 57. Europe Anti-Hypertensive Drugs Sales Market Share by Country in 2020
Figure 58. Europe Anti-Hypertensive Drugs Revenue Market Share by Country in 2020
Figure 59. Europe Anti-Hypertensive Drugs Sales Market Share by Type in 2020
Figure 60. Europe Anti-Hypertensive Drugs Sales Market Share by Application in 2020
Figure 61. Germany Anti-Hypertensive Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 62. France Anti-Hypertensive Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 63. UK Anti-Hypertensive Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 64. Italy Anti-Hypertensive Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 65. Russia Anti-Hypertensive Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 66. Middle East & Africa Anti-Hypertensive Drugs Sales Market Share by Country in 2020
Figure 67. Middle East & Africa Anti-Hypertensive Drugs Revenue Market Share by Country in 2020
Figure 68. Middle East & Africa Anti-Hypertensive Drugs Sales Market Share by Type in 2020
Figure 69. Middle East & Africa Anti-Hypertensive Drugs Sales Market Share by Application in 2020
Figure 70. Egypt Anti-Hypertensive Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 71. South Africa Anti-Hypertensive Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 72. Israel Anti-Hypertensive Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 73. Turkey Anti-Hypertensive Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 74. GCC Country Anti-Hypertensive Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles


★調査レポート[世界の降圧薬市場予測 2021年-2026年] (コード：LPI21MY9420)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の降圧薬市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の抗片頭痛薬市場予測 2021年-2026年
    LPI21MY9422 / LP Information / 2021年5月 / LPインフォメーション社の「抗片頭痛薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、トリプタン、麦角、その他など、用途別には、女性、男性などにセグメント区分してまとめました。抗片頭痛薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗片頭痛薬の世界市場概要（サマリー） ・抗片頭痛薬の企業別販売量・売上 ・抗片頭痛薬の企業別市場シェア ・抗片頭痛薬の世界市場規模 2016年-2021年：種類別（トリプタン、麦角、その他） ・抗片頭痛薬の世界市場規模 2016年-2021年：用途別（女性、男性） ・抗片頭痛薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗片頭痛薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti-Migraine Drugs will have significant change from previous year. By the most conservative estimates of global Anti-Migraine Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti-Migraine Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Migraine Drugs market by product type, application, key manufacturers and...
  • 世界の抗肥満薬市場予測 2021年-2026年
    LPI21MY9410 / LP Information / 2021年5月 / LPインフォメーション社の「抗肥満薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、経口薬、ダイエットパッチ、その他など、用途別には、男性、女性などにセグメント区分してまとめました。抗肥満薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗肥満薬の世界市場概要（サマリー） ・抗肥満薬の企業別販売量・売上 ・抗肥満薬の企業別市場シェア ・抗肥満薬の世界市場規模 2016年-2021年：種類別（経口薬、ダイエットパッチ、その他） ・抗肥満薬の世界市場規模 2016年-2021年：用途別（男性、女性） ・抗肥満薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗肥満薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti Obesity Drugs will have significant change from previous year. By the most conservative estimates of global Anti Obesity Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti Obesity Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti Obesity Drugs market by product type,...
  • 世界の抗消化性潰瘍薬市場予測 2021年-2026年
    LPI21MY9411 / LP Information / 2021年5月 / LPインフォメーション社の「抗消化性潰瘍薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、プロトンポンプ阻害剤（PPI）、カリウム競合性酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、抗生物質、潰瘍保護薬など、用途別には、胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD）などにセグメント区分してまとめました。抗消化性潰瘍薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗消化性潰瘍薬の世界市場概要（サマリー） ・抗消化性潰瘍薬の企業別販売量・売上 ・抗消化性潰瘍薬の企業別市場シェア ・抗消化性潰瘍薬の世界市場規模 2016年-2021年：種類別（プロトンポンプ阻害剤（PPI）、カリウム競合性酸遮断薬（P-CAB）、制酸剤、H2拮抗薬、抗生物質、潰瘍保護薬） ・抗消化性潰瘍薬の世界市場規模 2016年-2021年：用途別（胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD）） ・抗消化性潰瘍薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗消化性潰瘍薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti Peptic Ulcer Drugs will have significant change from previous year. By the most conservative estimates of global Anti Peptic Ulcer Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti Peptic Ulcer Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti Peptic Ulcer Drugs...
  • 世界の精神障害治療薬市場予測 2021年-2026年
    LPI21MY9588 / LP Information / 2021年5月 / LPインフォメーション社の「精神障害治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、統合失調症薬、抗うつ薬、抗精神病薬、抗不安薬、物質＆アルコール中毒治療薬、小児期＆青年期精神障害薬、認知障害治療薬、睡眠障害、その他など、用途別には、子供、青年、大人などにセグメント区分してまとめました。精神障害治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・精神障害治療薬の世界市場概要（サマリー） ・精神障害治療薬の企業別販売量・売上 ・精神障害治療薬の企業別市場シェア ・精神障害治療薬の世界市場規模 2016年-2021年：種類別（統合失調症薬、抗うつ薬、抗精神病薬、抗不安薬、物質＆アルコール中毒治療薬、小児期＆青年期精神障害薬、認知障害治療薬、睡眠障害、その他） ・精神障害治療薬の世界市場規模 2016年-2021年：用途別（子供、青年、大人） ・精神障害治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・精神障害治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Mental Disorders Drugs will have significant change from previous year. By the most conservative estimates of global Mental Disorders Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Mental Disorders Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Mental Disorders Drugs market by product type,...
  • 世界の双極性障害治療薬市場予測 2021年-2026年
    LPI21MY9449 / LP Information / 2021年5月 / LPインフォメーション社の「双極性障害治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、気分安定薬、抗精神病薬、抗うつ薬、その他薬品など、用途別には、病院、研究室、その他などにセグメント区分してまとめました。双極性障害治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・双極性障害治療薬の世界市場概要（サマリー） ・双極性障害治療薬の企業別販売量・売上 ・双極性障害治療薬の企業別市場シェア ・双極性障害治療薬の世界市場規模 2016年-2021年：種類別（気分安定薬、抗精神病薬、抗うつ薬、その他薬品） ・双極性障害治療薬の世界市場規模 2016年-2021年：用途別（病院、研究室、その他） ・双極性障害治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・双極性障害治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Bipolar Disorder Drugs will have significant change from previous year. By the most conservative estimates of global Bipolar Disorder Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Bipolar Disorder Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Bipolar Disorder Drugs market by product type,...
  • 世界の鎮咳薬市場予測 2021年-2026年
    LPI21MY9425 / LP Information / 2021年5月 / LPインフォメーション社の「鎮咳薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、中枢作用性鎮咳薬、局所作用性鎮咳薬など、用途別には、病院薬局、小売薬局、オンライン薬局などにセグメント区分してまとめました。鎮咳薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・鎮咳薬の世界市場概要（サマリー） ・鎮咳薬の企業別販売量・売上 ・鎮咳薬の企業別市場シェア ・鎮咳薬の世界市場規模 2016年-2021年：種類別（中枢作用性鎮咳薬、局所作用性鎮咳薬） ・鎮咳薬の世界市場規模 2016年-2021年：用途別（病院薬局、小売薬局、オンライン薬局） ・鎮咳薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・鎮咳薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Antitussive Drugs will have significant change from previous year. By the most conservative estimates of global Antitussive Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Antitussive Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Antitussive Drugs market by product type, application, key manufacturers and...
  • 世界のCD38モノクローナル抗体薬市場予測 2021年-2026年
    LPI21MY9468 / LP Information / 2021年5月 / LPインフォメーション社の「CD38モノクローナル抗体薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ダレツズマブ、イサルツキシマブ、人工毒素体など、用途別には、多発性骨髄腫、びまん性大細胞型B細胞リンパ腫、その他などにセグメント区分してまとめました。CD38モノクローナル抗体薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・CD38モノクローナル抗体薬の世界市場概要（サマリー） ・CD38モノクローナル抗体薬の企業別販売量・売上 ・CD38モノクローナル抗体薬の企業別市場シェア ・CD38モノクローナル抗体薬の世界市場規模 2016年-2021年：種類別（ダレツズマブ、イサルツキシマブ、人工毒素体） ・CD38モノクローナル抗体薬の世界市場規模 2016年-2021年：用途別（多発性骨髄腫、びまん性大細胞型B細胞リンパ腫、その他） ・CD38モノクローナル抗体薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・CD38モノクローナル抗体薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of CD38 Monoclonal Antibody Drugs will have significant change from previous year. By the most conservative estimates of global CD38 Monoclonal Antibody Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the CD38 Monoclonal Antibody Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of CD38 Monoclonal Antibody Drugs...
  • 世界のバイオエンジニアリングタンパク質医薬品市場予測 2021年-2026年
    LPI21MY9445 / LP Information / 2021年5月 / LPインフォメーション社の「バイオエンジニアリングタンパク質医薬品の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、組換えタンパク質医薬品、ペプチドホルモン、ワクチン、治療用酵素、モノクローナル抗体、サイトカイン、代替タンパク質、ペプチド抗生物質、血液製品など、用途別には、分画、バイオリアクター・微生物細胞発酵、遺伝子エンジニアリング、遺伝子組み換え生物、ファーミング、トランスジェニック微生物、植物・動物由来バイオエンジニアリングタンパク質薬剤、細胞培養、その他などにセグメント区分してまとめました。バイオエンジニアリングタンパク質医薬品のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・バイオエンジニアリングタンパク質医薬品の世界市場概要（サマリー） ・バイオエンジニアリングタンパク質医薬品の企業別販売量・売上 ・バイオエンジニアリングタンパク質医薬品の企業別市場シェア ・バイオエンジニアリングタンパク質医薬品の世界市場規模 2016年-2021年：種類別（組換えタンパク質医薬品、ペプチドホルモン、ワクチン、治療用酵素、モノクローナル抗体、サイトカイン、代替タンパク質、ペプチド抗生物質、血液製品） ・バイオエンジニアリングタンパク質医薬品の世界市場規模 2016年-2021年：用途別（分画、バイオリアクター・微生物細胞発酵、遺伝子エンジニアリング、遺伝子組み換え生物、ファーミング、トランスジェニック微生物、植物・動物由来バイオエンジニアリングタンパク質薬剤、細胞培養、その他） ・バイオエンジニアリングタンパク質医薬品の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・バイオエンジニアリングタンパク質医薬品のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Bioengineered Protein Drugs will have significant change from previous year. By the most conservative estimates of global Bioengineered Protein Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 81950 million in 2019. Over the next five years the Bioengineered Protein Drugs market will register a 4.2% CAGR in terms of revenue, the global market size will reach US$ 96520 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Bioengineered Protein Drugs market by product type,...
  • 世界の抗HA抗体市場予測 2021年-2026年
    LPI21MY9418 / LP Information / 2021年5月 / LPインフォメーション社の「抗HA抗体の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、IgM、IgG、IgA、その他など、用途別には、治療、研究、診断などにセグメント区分してまとめました。抗HA抗体のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗HA抗体の世界市場概要（サマリー） ・抗HA抗体の企業別販売量・売上 ・抗HA抗体の企業別市場シェア ・抗HA抗体の世界市場規模 2016年-2021年：種類別（IgM、IgG、IgA、その他） ・抗HA抗体の世界市場規模 2016年-2021年：用途別（治療、研究、診断） ・抗HA抗体の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗HA抗体のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of anti-HA Antibody will have significant change from previous year. By the most conservative estimates of global anti-HA Antibody market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the anti-HA Antibody market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of anti-HA Antibody market by product type, application, key manufacturers and...
  • 世界の心血管疾患治療薬市場予測 2021年-2026年
    LPI21MY9466 / LP Information / 2021年5月 / LPインフォメーション社の「心血管疾患治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ヘパリン、クマディン、セクトラル、ゼベタ、ロプレッサー、トプロロールXL、ノルバスク、ロットレル、その他など、用途別には、虚血性心疾患、脂質異常症、脳卒中、血栓症、アテローム性動脈硬化症、冠状動脈疾患、末梢動脈疾患、その他などにセグメント区分してまとめました。心血管疾患治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・心血管疾患治療薬の世界市場概要（サマリー） ・心血管疾患治療薬の企業別販売量・売上 ・心血管疾患治療薬の企業別市場シェア ・心血管疾患治療薬の世界市場規模 2016年-2021年：種類別（ヘパリン、クマディン、セクトラル、ゼベタ、ロプレッサー、トプロロールXL、ノルバスク、ロットレル、その他） ・心血管疾患治療薬の世界市場規模 2016年-2021年：用途別（虚血性心疾患、脂質異常症、脳卒中、血栓症、アテローム性動脈硬化症、冠状動脈疾患、末梢動脈疾患、その他） ・心血管疾患治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・心血管疾患治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Cardiovascular Disease Drugs will have significant change from previous year. By the most conservative estimates of global Cardiovascular Disease Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Cardiovascular Disease Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular Disease Drugs market by product type,...

    • ◆H&Iグローバルリサーチのお客様（例）◆